These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 24492423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
    Niioka T, Satoh S, Kagaya H, Numakura K, Inoue T, Saito M, Narita S, Tsuchiya N, Habuchi T, Miura M.
    Transplantation; 2012 Nov 27; 94(10):1013-9. PubMed ID: 23073468
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial.
    Wlodarczyk Z, Ostrowski M, Mourad M, Krämer BK, Abramowicz D, Oppenheimer F, Miller D, Dickinson J, Undre N.
    Ther Drug Monit; 2012 Apr 27; 34(2):143-7. PubMed ID: 22406656
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    Alloway R, Vanhaecke J, Yonan N, White M, Haddad H, Rábago G, Tymchak W, Diaz Molina B, Grimm M, Eiskjaer H, Karpf C, Undre N.
    J Heart Lung Transplant; 2011 Sep 27; 30(9):1003-10. PubMed ID: 21493098
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    van Hooff J, Van der Walt I, Kallmeyer J, Miller D, Dawood S, Moosa MR, Christiaans M, Karpf C, Undre N.
    Ther Drug Monit; 2012 Feb 27; 34(1):46-52. PubMed ID: 22249344
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation.
    Stifft F, Stolk LM, Undre N, van Hooff JP, Christiaans MH.
    Transplantation; 2014 Apr 15; 97(7):775-80. PubMed ID: 24686426
    [Abstract] [Full Text] [Related]

  • 8. Dose increase needed in most cystic fibrosis lung transplantation patients when changing from twice- to once-daily tacrolimus oral administration.
    Soto GAC, Ruiz-Antorán B, Laporta R, Sancho A, Lázaro MT, Herrera CP, Salcedo I, Cos MA, Torres F, Usetti P, Avendaño-Sola C.
    Eur J Clin Pharmacol; 2015 Jun 15; 71(6):715-722. PubMed ID: 25953736
    [Abstract] [Full Text] [Related]

  • 9. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
    Dumortier J, Guillaud O, Boillot O.
    Liver Transpl; 2013 May 15; 19(5):529-33. PubMed ID: 23483701
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C, Gatault P, Buchler M, Charpentier B, Thervet E, Cassuto E.
    Pharmacol Res; 2018 Mar 15; 129():84-94. PubMed ID: 29229354
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic Study of Conversion Between 2 Formulations of Once-daily Extended-release Tacrolimus in Stable Lung Transplant Patients.
    Sintes H, Sáez-Giménez B, Berastegui C, López-Meseguer M, Monforte V, Bravo C, Vima J, Gómez-Ollés S, Roman A.
    Transplantation; 2018 Oct 15; 102(10):e439-e446. PubMed ID: 29965950
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
    Kolonko A, Chudek J, Wiecek A.
    Transplant Proc; 2011 Oct 15; 43(8):2950-3. PubMed ID: 21996198
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
    Alloway RR, Eckhoff DE, Washburn WK, Teperman LW.
    Liver Transpl; 2014 May 15; 20(5):564-75. PubMed ID: 24493215
    [Abstract] [Full Text] [Related]

  • 20. Early Conversion From Twice-Daily Tacrolimus to Prolonged-Release Tacrolimus in Liver Transplantation: A Single-Center Experience.
    Ogura Y, Imai H, Kamei H, Hori T, Kurata N, Onishi Y.
    Ann Transplant; 2016 Jul 19; 21():448-55. PubMed ID: 27432248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.